ArticleThe Journal of infectious diseases2022

Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada.

Danuta M Skowronski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.